VIR logo

Vir Biotechnology, Inc. (VIR)

Profile

Full Name

Vir Biotechnology, Inc.

Ticker

NASDAQ: VIR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 11, 2019

Indexes

Not included

Website

https://www.vir.bio

Employees

408

Key Details

Price

$4.96(+2.06%)

Market cap

$689.03M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$74.20M(-13.90% YoY)

Annual EPS

-$3.83(+16.56% YoY)

PE ratio

-

Next earnings date

Oct 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $4.96
    VIR price is $4.96

    30-Day Relative Volume

    0.64
    VIR 30-day relative volume is 0.64

    Price Performance

    Price Today change

    +2.06%
    VIR price is up +2.06% today

    Price YTD change

    -32.43%
    VIR price is down -32.43% since January 1st

    Price 1-year change

    -37.45%
    VIR price is down -37.45% year-on-year

    Price 3-year change

    -75.22%
    VIR price is down -75.22% over the past 3 years

    Price Range

    Price All-time high

    $141.01
    VIR price is currently -96.48% below its historical high of $141.01

    Price 3-year low

    $4.16
    VIR price is currently +19.37% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $689.03M
    VIR market capitalization is $689.03 million

    Market cap 3-year change

    -74.05%
    VIR market capitalization is down -74.05% over the past 3 years

    Market cap All-time high

    $10.58B
    VIR market capitalization is currently -93.49% below its historical high of $10.58 billion

    Market cap sector rank

    67.7%
    VIR market capitalization is higher than 67.7% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.67%
    VIR shares outstanding is up +1.67% year-on-year

    Shares Outstanding 3-Year Change

    +4.73%
    VIR shares outstanding is up +4.73% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.42
    VIR beta is 1.42

    200-day SMA

    $6.63
    VIR price is currently -25.20% below its 200-day simple moving average

    50-day SMA

    $5.06
    VIR price is currently -2.04% below its 50-day simple moving average

    RSI

    47.45
    VIR 14-day relative strength index is 47.45

    Volume

    0.64
    VIR 30-day relative volume is 0.64

    ATR

    $0.30
    VIR average true range is $0.30

    10-day Historical Volatility

    75.92%
    VIR 10-day historical volatility is 75.92%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $74.20M
    VIR annual revenue is $74.20 million

    Revenue Analysts estimate

    $11.47M
    VIR annual revenue is currently +547.09% higher than the consensus analysts' forecast

    Revenue 1-year change

    -13.9%
    VIR annual revenue is down -13.9% year-on-year

    Revenue Sector rank

    65.89%
    VIR annual revenue is higher than 65.89% of companies in Healthcare sector

    EPS

    EPS

    -$3.83
    VIR annual earnings per share is -$3.83

    EPS Analysts estimate

    -$3.26
    VIR annual earnings per share is currently +17.36% higher than the consensus analysts' forecast

    EPS 1-year change

    +16.56%
    VIR annual earnings per share is up +16.56% year-on-year

    EPS Sector rank

    23.76%
    VIR annual earnings per share is higher than 23.76% of companies in Healthcare sector

    Profit

    Gross profit

    $58.80M
    VIR annual gross profit is $58.80 million

    Gross margin

    79.24%
    VIR annual gross profit margin is 79.24%

    Operating profit

    -$552.17M
    VIR annual operating income is -$552.17 million

    Operating margin

    -866.67%
    VIR annual operating profit margin is -866.67%

    Net income

    -$521.96M
    VIR annual net profit is -$521.96 million

    Net margin

    -819.25%
    VIR annual net profit margin is -819.25%

    Expenses

    Total expenses

    $615.88M
    VIR annual total expenses is $615.88 million

    Operating expenses

    $615.04M
    VIR annual total operating expenses is $615.04 million

    Cost of goods sold

    $15.40M
    VIR annual cost of goods sold is $15.40 million

    Selling, general & administrative expenses

    $119.03M
    VIR annual SGA is $119.03 million

    Depreciation and amortization

    $14.56M
    VIR annual depreciation & amortization is $14.56 million

    Interest expense

    $0.00
    VIR annual interest expense is $0.00

    Income tax

    -$1.15M
    VIR annual income tax is -$1.15 million

    EBIT & EBITDA

    EBIT

    -$552.17M
    VIR annual earnings before interest & taxes is -$552.17 million

    EBITDA

    -$537.61M
    VIR annual EBITDA is -$537.61 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.42B
    VIR annual total assets is $1.42 billion

    Non current assets

    $356.33M
    VIR annual long term assets is $356.33 million

    Current assets

    $1.04B
    VIR annual total current assets is $1.04 billion

    Cash and cash equivalents

    $222.95M
    VIR annual cash & cash equivalents is $222.95 million

    Accounts receivable

    -
    VIR annual accounts receivable value is unknown

    Inventory

    $0.00
    VIR annual inventory is $0.00

    Liabilities

    Total liabilities

    $273.20M
    VIR annual total liabilities is $273.20 million

    Long term liabilities

    $128.77M
    VIR annual total long term liabilities is $128.77 million

    Current liabilities

    $119.66M
    VIR annual total current liabilities is $119.66 million

    Accounts payable

    $5.08M
    VIR annual accounts payable is $5.08 million

    Debt

    Total debt

    $97.89M
    VIR annual total debt is $97.89 million

    Total debt 1-year change

    -21.4%
    VIR annual total debt is down -21.4% year-on-year

    Long term debt

    $90.14M
    VIR annual long term debt is $90.14 million

    Short term debt

    $7.75M
    VIR annual short term debt is $7.75 million

    Equity & Capital

    Shareholders equity

    $1.15B
    VIR annual stockholders equity is $1.15 billion

    Book value

    $1.15B
    VIR annual book value is $1.15 billion

    Retained earnings

    -$759.78M
    VIR annual retained earnings is -$759.78 million

    Working capital

    $922.80M
    VIR annual working capital is $922.80 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$446.35M
    VIR annual cash flow from operations is -$446.35 million

    Cash from operations 1-year change

    +42.69%
    VIR annual cash flow from operations is up +42.69% year-on-year

    Cash from investing

    $499.37M
    VIR annual cash flow from investing activities is $499.37 million

    Cash from investing 1-year change

    +203.33%
    VIR annual cash flow from investing activities is up +203.33% year-on-year

    Cash from financing

    $4.39M
    VIR annual cash flow from financing activities is $4.39 million

    Cash from financing 1-year change

    -41.34%
    VIR annual cash flow from financing activities is down -41.34% year-on-year

    CAPEX

    CAPEX

    $7.30M
    VIR annual capital expenditures is $7.30 million

    CAPEX 1-year change

    -66.16%
    VIR annual capital expenditures is down -66.16% year-on-year

    Free Cash Flow

    Free cash flow

    -$453.65M
    VIR annual free cash flow is -$453.65 million

    Free cash flow 1-year change

    +43.32%
    VIR annual free cash flow is up +43.32% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    79.24%
    VIR annual gross profit margin is 79.24%

    Operating margin

    -866.67%
    VIR annual operating profit margin is -866.67%

    Net margin

    -819.25%
    VIR annual net profit margin is -819.25%

    ROA & ROE

    ROA

    -30.85%
    VIR annual return on assets is -30.85%

    ROE

    -38.09%
    VIR annual return on equity is -38.09%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    VIR price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    VIR price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.73
    VIR price to book ratio is 0.73

    PB ratio Sector rank

    29.18%
    VIR price to book ratio is higher than 29.18% of companies in Healthcare sector

    PS Ratio

    PS ratio

    36.26
    VIR price to sales ratio is 36.26

    PS ratio Sector rank

    84.28%
    VIR price to sales ratio is higher than 84.28% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $97.02M
    VIR enterprise value is $97.02 million

    Enterprise value Sector rank

    46.11%
    VIR enterprise value is higher than 46.11% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.17
    VIR EV/EBITDA is -0.17

    EV/EBITDA Sector rank

    60.81%
    VIR EV/EBITDA is higher than 60.81% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    8.71
    VIR annual current ratio is 8.71

    Quick ratio

    8.71
    VIR annual quick ratio is 8.71

    Leverage

    Debt to equity

    0.00
    VIR annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    VIR annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    2
    VIR piotroski f-score is 2

    Altman Z-Score

    0.32
    VIR altman z-score is 0.32

    Analyst ratings

    Recent major analysts updates

    Sep 15, 25 HC Wainwright & Co.
    Buy
    Sep 3, 25 Evercore ISI Group
    Outperform
    Aug 27, 25 B of A Securities
    Buy
    Jul 11, 25 Raymond James
    Outperform
    May 22, 25 Needham
    Buy
    May 12, 25 Needham
    Buy
    Apr 17, 25 Goldman Sachs
    Buy
    Feb 28, 25 HC Wainwright & Co.
    Buy
    Feb 28, 25 Barclays
    Overweight
    Feb 27, 25 Needham
    Buy

    Institutional Ownership

    Screeners with VIR included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Vir Biotechnology, Inc.?
    • Does Vir Biotechnology, Inc. pay dividends?
    • What sector is Vir Biotechnology, Inc. in?
    • What industry is Vir Biotechnology, Inc. in?
    • What country is Vir Biotechnology, Inc. based in?
    • When did Vir Biotechnology, Inc. go public?
    • Is Vir Biotechnology, Inc. in the S&P 500?
    • Is Vir Biotechnology, Inc. in the NASDAQ 100?
    • Is Vir Biotechnology, Inc. in the Dow Jones?
    • When was Vir Biotechnology, Inc.'s last earnings report?
    • When does Vir Biotechnology, Inc. report earnings?

    What is the ticker symbol for Vir Biotechnology, Inc.?

    The ticker symbol for Vir Biotechnology, Inc. is NASDAQ:VIR

    Does Vir Biotechnology, Inc. pay dividends?

    No, Vir Biotechnology, Inc. does not pay dividends

    What sector is Vir Biotechnology, Inc. in?

    Vir Biotechnology, Inc. is in the Healthcare sector

    What industry is Vir Biotechnology, Inc. in?

    Vir Biotechnology, Inc. is in the Biotechnology industry

    What country is Vir Biotechnology, Inc. based in?

    Vir Biotechnology, Inc. is headquartered in United States

    When did Vir Biotechnology, Inc. go public?

    Vir Biotechnology, Inc.'s initial public offering (IPO) was on October 11, 2019

    Is Vir Biotechnology, Inc. in the S&P 500?

    No, Vir Biotechnology, Inc. is not included in the S&P 500 index

    Is Vir Biotechnology, Inc. in the NASDAQ 100?

    No, Vir Biotechnology, Inc. is not included in the NASDAQ 100 index

    Is Vir Biotechnology, Inc. in the Dow Jones?

    No, Vir Biotechnology, Inc. is not included in the Dow Jones index

    When was Vir Biotechnology, Inc.'s last earnings report?

    Vir Biotechnology, Inc.'s most recent earnings report was on August 6, 2025

    When does Vir Biotechnology, Inc. report earnings?

    The next expected earnings date for Vir Biotechnology, Inc. is October 30, 2025
    On this page